Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs... see more

TSX:TH - Post Discussion

View:
Post by palinc2000 on Apr 08, 2022 1:18pm

New PR

Marsolais seems very excited even though its pre clunical
Comment by palinc2000 on Apr 08, 2022 1:19pm
https://stockhouse.com/news/press-releases/2022/04/08/theratechnologies-presents-new-in-vivo-th1902-preclinical-data-demonstrating
Comment by SPCEO1 on Apr 08, 2022 1:31pm
From my non-scientist vantage point, it does sound like impressive findings but we are already beyond focusing on pre-clinical info and are more than ready to hear the more important human trial info. And we should her something on that pretty soon. Now, the science team here may tell us this updated info on pre-clincial work actually does contain something very noteworthy that should not be ...more  
Comment by palinc2000 on Apr 08, 2022 1:47pm
For a rare occasion I will do some tea leave reading!!!The PR could have been released without Marsolais showing that much excitement....Why would he show so much superlative just weeks or maybe days ahead of releasing clinical results  unless he does not mind losing face ,,,, END of reading tea leaves for now!!!
Comment by palinc2000 on Apr 08, 2022 1:49pm
Remarkable progress
Comment by palinc2000 on Apr 08, 2022 1:58pm
My hopemeter going up a notch from neutral to slightly positive.....
Comment by realitycheck4u on Apr 08, 2022 2:06pm
This post has been removed in accordance with Community Policy
Comment by Biobob on Apr 08, 2022 2:07pm
Great news for Minimouse... 
Comment by longterm56 on Apr 08, 2022 2:14pm
Man .. this crowd is getting ugly!!  Hang on, all, we haven't yet heard from those who really know!!!!     -LT
Comment by jfm1330 on Apr 08, 2022 3:13pm
It would be strange to have this PR out with positive comments by Marsolais and absolutely no sign of efficacy in phase Ia while it is close to be completed. I know they would be able to hide behind the excuse that phase Ia is not designed to show efficacy, but it would be surprising given that they are still pushing preclinical data pointing at efficacy against very advanced and resistant cancers ...more  
Comment by palinc2000 on Apr 08, 2022 3:23pm
That was my line!!!! please dont plagiarize LOL!!! Today is probably the best Friday in  a long time ....maybe an inflection point 
Comment by Biobob on Apr 08, 2022 3:26pm
Hey if we get together we can buy 100 shares at the close to prop it up.. just like the AO that low closes the stock just about every day that goes buy.
Comment by qwerty22 on Apr 08, 2022 3:51pm
The abstracts were submitted awhile back. The R&D behind these posters has probably been ongoing for a year or more. You think if the half dozen to a dozen patients who've had high doses of th1902 haven't shown a response that they would pull these posters from the conference? Of course not! None of this has anything to do with how the Ph1 trial is progressing. Like every other biotech ...more  
Comment by palinc2000 on Apr 08, 2022 4:01pm
I agree but the superlatives would not have been part of the PR .......according to my reading the tea leaves 
Comment by qwerty22 on Apr 09, 2022 8:07am
I think you might be able to boil down our definition of success as something that moves the stock price. I think their definition of ongoing success is something that keeps the program alive from a clinical and commercial perspective. I don't believe both those things completely overlap. So the superlatives might be their just to support their view of things. I was probably too harsh with my ...more  
Comment by palinc2000 on Apr 09, 2022 8:48am
I really appreciate how measured you are in your posts.....Your goal is to search for the truth and you are able to recognize grey areas  in your opinions as the case may be...
Comment by Bucknelly21 on Apr 09, 2022 9:25am
Look at pal trying to make jfm mad by complimenting qwuerty haha
Comment by palinc2000 on Apr 09, 2022 9:48am
How can that be? Jfm has me snd Qwerty on Ignore .He does not have access to my posts You are missing the real point.Qwerty is an outstanding poster and I think I am not alone to think so [ quote=Bucknelly21]Look at pal trying to make jfm mad by complimenting qwuerty haha[/quote]  
Comment by Bucknelly21 on Apr 09, 2022 12:14pm
Because if he doesn't log in he can aee all the messages 
Comment by SPCEO1 on Apr 09, 2022 4:03pm
You are definitely not alone thinking that! Thanks Qwerty for your many outstanding posts.  [/quote]
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities